A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. INVO Bioscience Inc’s current trading price is -93.06% away from its 52-week high, while its distance from the 52-week low is 244.00%. The stock’s price range for this time frame has been between $0.50 and $24.79. The trading volume of the company’s shares in the Healthcare reached around 0.61 million for the day, which was evidently lower than the average daily volume of 3.7 million over the last three months.
The current stock price for INVO Bioscience Inc (INVO) is $1.72. The stock experienced a significant increase during the last trading session, reaching $1.91 after opening at $1.72. It dipped to a low of $1.71 before ultimately closing at $1.81.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
INVO Bioscience Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $24.79 on 11/21/22, while the lowest price during the same period was $0.50 on 10/19/23.
How Financial Performance Impacts Market Capitalization
INVO Bioscience Inc (INVO) has experienced a quarterly rise of 14.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.25M and boasts a workforce of 15 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.8281, with a change in price of -2.4200. Similarly, INVO Bioscience Inc recorded 2,539,139 in trading volume during the last 100 days, posting a change of -58.45%.
How INVO’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for INVO stands at 23.81. Similarly, the long-term debt-to-equity ratio is also 18.16.
INVO Stock Stochastic Average
INVO Bioscience Inc’s raw stochastic average for the past 50 days is currently at 48.03%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 59.24%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 54.45% and 54.92%, respectively.
INVO Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -79.71% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -74.71%. Over the past 30 days, the price of INVO has fallen by 218.52%. And in the last five days, it has surged by 6.83%.
